Unknown

Dataset Information

Comprehensive analysis of pan-cancer reveals potential of ASF1B as a prognostic and immunological biomarker.


ABSTRACT:

Background

Anti-silencing function 1 (ASF1) is a conserved histone H3-H4 chaperone protein. ASF1B, a paralog of ASF1, acts by promoting cell proliferation and influencing cell cycle progression. Although there is some evidence demonstrating that ASF1B plays a key role in the development, progression, and prognosis of certain cancers, there are no pan-cancer analyses of ASF1B.

Methods

We used a range of bioinformatics approaches to investigate the predictive role of ASF1B, including its correlation with prognosis, tumor mutational burden (TMB), microsatellite instability (MSI), tumor microenvironment (TME), and immune cell infiltration, in diverse cancer types.

Results

We found that ASF1B was highly expressed in 22 cancers and was negatively correlated with the prognos

SUBMITTER: Hu X 

PROVIDER: S-EPMC8495294 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature